Replies to post #105884 on Biotech Values

[DewDiligence]

Who cares? Teva said t-enox facilities had been inspected and had presumably passed, according to Ms. Chen. I fail to see the consequence of whose facilities they are.

If you hypothetically knew that Teva’s Lovenox were some other company’s drug and that Teva were merely a marketing arm, it wouldn’t affect your assessment of this drug’s approvability? I find your statement astonishing.

[Regulardoc]

Hate to be brain dead on this one, but did TEVA specify that it was the t-enoxaparin facility (or facilties) that was/were inspected, or simply the heparin feedstock facilites that had been inspected?

Thanks